Health
Can Moderna shares rally on higher vaccine efficacy against Delta variant? – ig.com
Covid-19 vaccine maker Moderna’s stock has been on a tear this year, hitting record highs.
- Moderna (Nasdaq: MRNA) share price falls to US$456.76 per share
- The US biotech said it will not exceed its 2021 vaccine production target
- Modernas jab may be more effective against the Delta variant than its rivals shot, a study suggested
- Feeling bullish or…
Continue Reading
-
General16 hours agoFrom Humpty Doo to the bush, these voters’ views reflect the challenge for federal politicians
-
Noosa News17 hours agoThe Pedro Pascal-Led Fantastic Four Face Julia Garner’s Silver Surfer in the New Full ‘First Steps’ Trailer
-
General14 hours agoNew Zealand wants more ‘automated decision-making’ in its welfare system. Could that lead to Robodebt 2.0?
-
Noosa News20 hours agoMeet Llew O’Brien, LNP | Noosa Today